Lumos Diagnostics (ASX:LDX) specializes in rapid, cost-effective and complete point-of-care (POC) diagnostic test technology to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers customized assay development and manufacturing services for POC tests and proprietary digital reader platforms. Lumos also directly develops, manufactures and commercializes novel Lumos-branded POC tests that target infectious and inflammatory diseases.
|
|
|
51-200 employees
View all Lumos Diagnostics employees
|
|
Biotechnology
|
|
2724 Loker Ave West, Carlsbad, California 92010, US
|
The decision makers in Lumos Diagnostics are Annie Bell, Catherine Robson, Chris Lin, etc. Click to Find Lumos Diagnostics decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.